Investigators at Montefiore Einstein, Regenstrief Institute and Indiana University School of Medicine received an $11 million grant from the National Institutes of Health (NIH) to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.
The grant will be used to conduct a clinical trial that will recruit 6,600 participants from 22 primary care sites in the Bronx and Indiana. The goal is to improve the diagnosis of mild cognitive impairment (MCI) and dementia as well as to raise the level of care for cognitively impaired patients.
The five-minute screening tool was designed to reduce disparities in pre-dementia and dementia diagnosis and treatment. It was developed to be used on people from a range of racial and ethnic backgrounds, education levels and socioeconomic circumstances.